THANK YOU FOR SUBSCRIBING
Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Perineologic is trying to strengthen its leadership team with the appointment of Jim Fortune as the president and the promotion of Matthew J. Allaway to CEO.
Fremont, CA: “We are at a significant stage of growth at the company and attracting top talent and further strengthening our leadership team is essential to our success,” states Dr. Allaway. Jim Fortune has been named president of Perineologic, a subsidiary of Corbin Clinical Resources, Inc. He will be responsible for the company's corporate strategy and operational management. Mr. Fortune brings more than 35 years of experience in the medical device sector to Perineologic. Perineologic also promoted Matthew J. Allaway, DO, who had previously served as president, to chief executive officer. Mr. Fortune will report to Dr. Allaway directly.
Mr. Fortune previously worked as the chief operating officer of Ocular Therapeutix, Inc., where he oversaw the start-internal up's operations as it grew into a public business with an early-stage, PMA-approved commercial device, and several Phase 2 and Phase 3 drug delivery devices. He was previously the chief operating officer of AccessClosure (which was bought by Cardinal Health, Inc.) and Incept, LLC, an intellectual property holding company that generates and operates medical device start-up companies.
“The overall goal for anyone in the medical device industry is to make a meaningful difference in the lives of patients and improve quality of care. I was attracted to Perineologic because of the significant potential that the PrecisionPoint™ Transperineal Access System has to positively transform the standard of care in prostate biopsy by providing a more streamlined procedure process for clinicians and important benefits for patients. I am excited to join this innovative team and support widespread adoption of this novel biopsy technique,” comments Mr. Fortune.
Dr. Allaway is the founder of Perineologic and has spent the last 20 years as a practicing urologist and managing partner at Urology Associates in Cumberland, Maryland, specializing in prostate cancer and female urology.
“We are pleased to have Jim join our team as his broad industry experience, including supporting the commercialization, manufacturing and ongoing sales strategies of new medical devices, will be valuable as we continue our efforts to expand market adoption of PrecisionPoint. I look forward to working with him closely in my new role.” states Dr. Allaway.Perineologic is trying to strengthen its leadership team with the appointment of Jim Fortune as the president and the promotion of Matthew J. Allaway to CEO.
Fremont, CA
“We are at a significant stage of growth at the company and attracting top talent and further strengthening our leadership team is essential to our success,” states Dr. Allaway. Jim Fortune has been named president of Perineologic, a subsidiary of Corbin Clinical Resources, Inc. He will be responsible for the company's corporate strategy and operational management. Mr. Fortune brings more than 35 years of experience in the medical device sector to Perineologic. Perineologic also promoted Matthew J. Allaway, DO, who had previously served as president, to chief executive officer. Mr. Fortune will report to Dr. Allaway directly.
Mr. Fortune previously worked as the chief operating officer of Ocular Therapeutix, Inc., where he oversaw the start-internal up's operations as it grew into a public business with an early-stage, PMA-approved commercial device, and several Phase 2 and Phase 3 drug delivery devices. He was previously the chief operating officer of AccessClosure (which was bought by Cardinal Health, Inc.) and Incept, LLC, an intellectual property holding company that generates and operates medical device start-up companies.
“The overall goal for anyone in the medical device industry is to make a meaningful difference in the lives of patients and improve quality of care. I was attracted to Perineologic because of the significant potential that the PrecisionPoint™ Transperineal Access System has to positively transform the standard of care in prostate biopsy by providing a more streamlined procedure process for clinicians and important benefits for patients. I am excited to join this innovative team and support widespread adoption of this novel biopsy technique,” comments Mr. Fortune.
Dr. Allaway is the founder of Perineologic and has spent the last 20 years as a practicing urologist and managing partner at Urology Associates in Cumberland, Maryland, specializing in prostate cancer and female urology.
“We are pleased to have Jim join our team as his broad industry experience, including supporting the commercialization, manufacturing and ongoing sales strategies of new medical devices, will be valuable as we continue our efforts to expand market adoption of PrecisionPoint. I look forward to working with him closely in my new role.” states Dr. Allaway.
Read Also
